A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
As a synthetic analogue of vasopressin, desmopressin or DDAVP has well established hemostatic properties. We present a review of DDAVP and summarize the clinical and laboratory evidence for its use in hemophilia A, von Willebrand disease (VWD), platelet function disorders, uremia, liver cirrhosis, a...
Saved in:
| Main Authors: | Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/7/967 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma proteomics in patients with von Willebrand disease and hemophilia A highlights von Willebrand factor as main determinant of response to desmopressin treatment
by: Jessica del Castillo Alferez, et al.
Published: (2025-03-01) -
Clinical significance of diagnostic algorithm in detection of mild hemostasis disorders in women with menorrhagia
by: Đukić Svetlana M., et al.
Published: (2020-01-01) -
Oral post-surgical complications in patients with hemophilia and von Willebrand disease
by: Luisa Catarina Porfirio de Sousa, et al.
Published: (2025-07-01) -
History of clinical applications of desmopressin
by: Lennox R. Ksido, et al.
Published: (2024-12-01) -
Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)